Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-intensity Interval Training as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction: A Prospective, Single-blind, Randomized Controlled Trial

NCT03184311 is registered in ClinicalTrials.gov with University of Basel as lead sponsor.

NCT NCT03184311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03184311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-intensity Interval Training as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction: A Prospective, Single-blind, Randomized Controlled Trial
Lead sponsor
University of Basel
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2020
Completion date
March 31, 2023
Enrollment
86 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with normal ejection fraction